Jawed vertebrates use V(D)J recombination of immunoglobulin and T cell receptors, whereas jawless vertebrates rearrange variable lymphocyte receptors encoding leucine-rich repeats to form an ...

MIT neuroscientists have made a breakthrough in treating fragile X syndrome by leveraging a novel neurotransmitter signaling ...

A recent genetic study has provided new insights into how glucagon-like peptide-1 (GLP-1) receptor agonists aid weight loss.

HR+/HER2- breast cancer involves cells that test positive for hormone receptors and negative for HER2 proteins. It's the most ...

N-methyl-D-aspartate (NMDA) receptors are critical for higher-order nervous system function, but in previously published protocols to convert human induced pluripotent stem cells (iPSCs) to mature ...

The ∼45 olfactory neuron classes in Drosophila express different odorant receptors, which determine the range of odorants that the neurons sense. Axons from each class of olfactory neurons project to ...

In a surprising discovery, scientists have found that the heart possesses 'sweet taste' receptors, similar to those on our tongues, and that stimulating these receptors with sweet substances can ...

Many patients with overweight or obesity discontinue GLP-1 receptor agonist therapy within 1 year, with higher discontinuation rates seen for those without type 2 diabetes.

MIT researchers discovered a way to treat Fragile X syndrome by targeting NMDA receptors, restoring synaptic balance and ...

Evidence suggests no increased risk The use of glucagon-like peptide-1 (GLP-1) receptor agonists has surged in recent years, driven by their benefits in glucose control in type 2 diabetes, weight ...